{"pmid":32406213,"title":"Recommendations for gynecologic cancer care during the COVID-19 pandemic.","text":["Recommendations for gynecologic cancer care during the COVID-19 pandemic.","J Gynecol Oncol","32406213"],"journal":"J Gynecol Oncol","date":"2020-05-15T11:00:00Z","year":2020,"_id":"32406213","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.3802/jgo.2020.31.e69","topics":["Prevention"],"weight":1,"_version_":1666950579808632832,"score":9.490897,"similar":[{"pmid":32458596,"title":"Recommendations on management of gynecological malignancies during the COVID-19 pandemic: perspectives from Chinese gynecological oncologists.","text":["Recommendations on management of gynecological malignancies during the COVID-19 pandemic: perspectives from Chinese gynecological oncologists.","The outbreak of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 has rapidly spread globally. Cancer patients are at a higher risk of being infected with the coronavirus and are more likely to develop severe complications, as compared to the general population. The increasing spread of COVID-19 presents challenges for the clinical care of patients with gynecological malignancies. Concerted efforts should be put into managing gynecological malignancies in an orderly manner by strictly implementing the measures that are specifically developed for controlling the spread of COVID-19. We have drafted Recommendations on Management of Gynecological Malignancies during the COVID-19 Pandemic based on our experience on controlling COVID-19 pandemic in China. We recommend that patients with gynecological malignancies should be managed in hierarchical and individualized manners in combination with local conditions related to COVID-19. Medical care decision should be balanced between controlling COVID-19 pandemic spread and timely diagnosis and treatment for gynecologic oncology patients.","J Gynecol Oncol","Wang, Yingmei","Zhang, Shiqian","Wei, Lihui","Lin, Zhongqiu","Wang, Xinyu","Wang, Jianliu","Hua, Keqin","Cui, Manhua","Wang, Jiandong","Wang, Shixuan","Di, Wen","Wang, Yudong","An, Ruifang","Xi, Mingrong","Guo, Ruixia","Zhou, Qi","Xie, Xing","Xue, Fengxia","32458596"],"abstract":["The outbreak of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 has rapidly spread globally. Cancer patients are at a higher risk of being infected with the coronavirus and are more likely to develop severe complications, as compared to the general population. The increasing spread of COVID-19 presents challenges for the clinical care of patients with gynecological malignancies. Concerted efforts should be put into managing gynecological malignancies in an orderly manner by strictly implementing the measures that are specifically developed for controlling the spread of COVID-19. We have drafted Recommendations on Management of Gynecological Malignancies during the COVID-19 Pandemic based on our experience on controlling COVID-19 pandemic in China. We recommend that patients with gynecological malignancies should be managed in hierarchical and individualized manners in combination with local conditions related to COVID-19. Medical care decision should be balanced between controlling COVID-19 pandemic spread and timely diagnosis and treatment for gynecologic oncology patients."],"journal":"J Gynecol Oncol","authors":["Wang, Yingmei","Zhang, Shiqian","Wei, Lihui","Lin, Zhongqiu","Wang, Xinyu","Wang, Jianliu","Hua, Keqin","Cui, Manhua","Wang, Jiandong","Wang, Shixuan","Di, Wen","Wang, Yudong","An, Ruifang","Xi, Mingrong","Guo, Ruixia","Zhou, Qi","Xie, Xing","Xue, Fengxia"],"date":"2020-05-28T11:00:00Z","year":2020,"_id":"32458596","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.3802/jgo.2020.31.e68","keywords":["covid-19","gynecological malignancies","management","pandemic","recommendations"],"locations":["China","Chinese"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1668141322609885184,"score":53.998215},{"pmid":32247066,"pmcid":"PMC7118621","title":"Recommendations for the surgical management of gynecological cancers during the COVID-19 pandemic - FRANCOGYN group for the CNGOF.","text":["Recommendations for the surgical management of gynecological cancers during the COVID-19 pandemic - FRANCOGYN group for the CNGOF.","INTRODUCTION: In the context of the COVID-19 pandemic, specific recommendations are required for the management of patients with gynecologic cancer. MATERIALS AND METHOD: The FRANCOGYN group of the National College of French Gynecologists and Obstetricians (CNGOF) convened to develop recommendations based on the consensus conference model. RESULTS: If a patient with a gynecologic cancer presents with COVID-19, surgical management should be postponed for at least 15 days. For cervical cancer, radiotherapy and concomitant radiochemotherapy could replace surgery as first-line treatment and the value of lymph node staging should be reviewed on a case-by-case basis. For advanced ovarian cancers, neoadjuvant chemotherapy should be preferred over primary cytoreduction surgery. It is legitimate not to perform hyperthermic intraperitoneal chemotherapy during the COVID-19 pandemic. For patients who are scheduled to undergo interval surgery, chemotherapy can be continued and surgery performed after 6 cycles. For patients with early stage endometrial cancer of low and intermediate preoperative ESMO risk, hysterectomy with bilateral adnexectomy combined with a sentinel lymph node procedure is recommended. Surgery can be postponed for 1-2 months in low-risk endometrial cancers (FIGO Ia stage on MRI and grade 1-2 endometrioid cancer on endometrial biopsy). For patients of high ESMO risk, the MSKCC algorithm (combining PET-CT and sentinel lymph node biopsy) should be applied to avoid pelvic and lumbar-aortic lymphadenectomy. CONCLUSION: During the COVID-19 pandemic, management of a patient with cancer should be adapted to limit the risks associated with the virus without incurring loss of chance.","J Gynecol Obstet Hum Reprod","Akladios, Cherif","Azais, Henri","Ballester, Marcos","Bendifallah, Sofiane","Bolze, Pierre-Adrien","Bourdel, Nicolas","Bricou, Alexandre","Canlorbe, Geoffroy","Carcopino, Xavier","Chauvet, Pauline","Collinet, Pierre","Coutant, Charles","Dabi, Yohann","Dion, Ludivine","Gauthier, Tristan","Graesslin, Olivier","Huchon, Cyrille","Koskas, Martin","Kridelka, Frederic","Lavoue, Vincent","Lecointre, Lise","Mezzadri, Matthieu","Mimoun, Camille","Ouldamer, Lobna","Raimond, Emilie","Touboul, Cyril","32247066"],"abstract":["INTRODUCTION: In the context of the COVID-19 pandemic, specific recommendations are required for the management of patients with gynecologic cancer. MATERIALS AND METHOD: The FRANCOGYN group of the National College of French Gynecologists and Obstetricians (CNGOF) convened to develop recommendations based on the consensus conference model. RESULTS: If a patient with a gynecologic cancer presents with COVID-19, surgical management should be postponed for at least 15 days. For cervical cancer, radiotherapy and concomitant radiochemotherapy could replace surgery as first-line treatment and the value of lymph node staging should be reviewed on a case-by-case basis. For advanced ovarian cancers, neoadjuvant chemotherapy should be preferred over primary cytoreduction surgery. It is legitimate not to perform hyperthermic intraperitoneal chemotherapy during the COVID-19 pandemic. For patients who are scheduled to undergo interval surgery, chemotherapy can be continued and surgery performed after 6 cycles. For patients with early stage endometrial cancer of low and intermediate preoperative ESMO risk, hysterectomy with bilateral adnexectomy combined with a sentinel lymph node procedure is recommended. Surgery can be postponed for 1-2 months in low-risk endometrial cancers (FIGO Ia stage on MRI and grade 1-2 endometrioid cancer on endometrial biopsy). For patients of high ESMO risk, the MSKCC algorithm (combining PET-CT and sentinel lymph node biopsy) should be applied to avoid pelvic and lumbar-aortic lymphadenectomy. CONCLUSION: During the COVID-19 pandemic, management of a patient with cancer should be adapted to limit the risks associated with the virus without incurring loss of chance."],"journal":"J Gynecol Obstet Hum Reprod","authors":["Akladios, Cherif","Azais, Henri","Ballester, Marcos","Bendifallah, Sofiane","Bolze, Pierre-Adrien","Bourdel, Nicolas","Bricou, Alexandre","Canlorbe, Geoffroy","Carcopino, Xavier","Chauvet, Pauline","Collinet, Pierre","Coutant, Charles","Dabi, Yohann","Dion, Ludivine","Gauthier, Tristan","Graesslin, Olivier","Huchon, Cyrille","Koskas, Martin","Kridelka, Frederic","Lavoue, Vincent","Lecointre, Lise","Mezzadri, Matthieu","Mimoun, Camille","Ouldamer, Lobna","Raimond, Emilie","Touboul, Cyril"],"date":"2020-04-05T11:00:00Z","year":2020,"_id":"32247066","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.1016/j.jogoh.2020.101729","keywords":["covid-19","guideline","gynaecological cancer","management"],"locations":["ovarian"],"topics":["Prevention"],"weight":1,"_version_":1666138492073148416,"score":45.137157},{"pmid":32471012,"title":"Practical recommendations for gynecologic surgery during the COVID-19 pandemic.","text":["Practical recommendations for gynecologic surgery during the COVID-19 pandemic.","Surgery in suspected/confirmed COVID-19 patients is a high-risk venture. In infected patients, COVID-19 is present in the body cavity. During surgery it could be nebulized in the spray generated by surgical instruments and could theoretically infect members of the surgical team. Nevertheless, some surgical gynecologic pathologies cannot be postponed. We present a list of the most frequent gynecologic diseases and recommendations on their surgical management during the COVID-19 pandemic, based on expert opinion, current available information, and international scientific society recommendations to support the work of gynecologists worldwide. In brief, any kind of surgical treatment should be scrutinized and postponed if possible. Nonoperative conservative treatment including pharmacological therapies for hormone-sensitive pathologies should be implemented. Health risk assessment by patient history and COVID-19 test before elective surgery are pivotal to protect both patients and healthcare providers. In confirmed COVID-19 patients or highly suspected cases, elective surgery should be postponed until full recovery.","Int J Gynaecol Obstet","Chiofalo, Benito","Baiocco, Ermelinda","Mancini, Emanuela","Vocaturo, Giuseppe","Cutillo, Giuseppe","Vincenzoni, Cristina","Bruni, Simone","Bruno, Valentina","Mancari, Rosanna","Vizza, Enrico","32471012"],"abstract":["Surgery in suspected/confirmed COVID-19 patients is a high-risk venture. In infected patients, COVID-19 is present in the body cavity. During surgery it could be nebulized in the spray generated by surgical instruments and could theoretically infect members of the surgical team. Nevertheless, some surgical gynecologic pathologies cannot be postponed. We present a list of the most frequent gynecologic diseases and recommendations on their surgical management during the COVID-19 pandemic, based on expert opinion, current available information, and international scientific society recommendations to support the work of gynecologists worldwide. In brief, any kind of surgical treatment should be scrutinized and postponed if possible. Nonoperative conservative treatment including pharmacological therapies for hormone-sensitive pathologies should be implemented. Health risk assessment by patient history and COVID-19 test before elective surgery are pivotal to protect both patients and healthcare providers. In confirmed COVID-19 patients or highly suspected cases, elective surgery should be postponed until full recovery."],"journal":"Int J Gynaecol Obstet","authors":["Chiofalo, Benito","Baiocco, Ermelinda","Mancini, Emanuela","Vocaturo, Giuseppe","Cutillo, Giuseppe","Vincenzoni, Cristina","Bruni, Simone","Bruno, Valentina","Mancari, Rosanna","Vizza, Enrico"],"date":"2020-05-30T11:00:00Z","year":2020,"_id":"32471012","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1002/ijgo.13248","keywords":["covid-19","cervical cancer","coronavirus","endometrial cancer","endometriosis","gynecology","laparoscopy","myoma","ovarian cancer","surgery","urogynecology","vulvar cancer"],"topics":["Prevention"],"weight":1,"_version_":1668420887302373376,"score":44.307682},{"pmid":32430141,"title":"[Gynecologic surgery in the era of COVID-19 - Recommendations for deconfinement].","text":["[Gynecologic surgery in the era of COVID-19 - Recommendations for deconfinement].","Gynecol Obstet Fertil Senol","Canis, M","Descamps, P","Dubernard, G","Estrade, J-P","Mourtialon, P","Fernandez, H","32430141"],"journal":"Gynecol Obstet Fertil Senol","authors":["Canis, M","Descamps, P","Dubernard, G","Estrade, J-P","Mourtialon, P","Fernandez, H"],"date":"2020-05-21T11:00:00Z","year":2020,"_id":"32430141","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.gofs.2020.05.004","keywords":["covid","chirurgie gynecologique","deconfinement","deconfinement","gynecologic surgery"],"topics":["Prevention"],"weight":1,"_version_":1667342288348512256,"score":41.60227},{"pmid":32221023,"title":"COVID-19 Global Pandemic: Options for Management of Gynecologic Cancers.","text":["COVID-19 Global Pandemic: Options for Management of Gynecologic Cancers.","Int J Gynecol Cancer","Ramirez, Pedro T","Chiva, Luis","Eriksson, Ane Gerda Z","Frumovitz, Michael","Fagotti, Anna","Gonzalez Martin, Antonio","Jhingran, Anuja","Pareja, Rene","32221023"],"journal":"Int J Gynecol Cancer","authors":["Ramirez, Pedro T","Chiva, Luis","Eriksson, Ane Gerda Z","Frumovitz, Michael","Fagotti, Anna","Gonzalez Martin, Antonio","Jhingran, Anuja","Pareja, Rene"],"date":"2020-03-30T11:00:00Z","year":2020,"_id":"32221023","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.1136/ijgc-2020-001419","keywords":["cervical cancer","ovarian cancer","pathology","radiation","surgery"],"topics":["Prevention","Treatment"],"weight":1,"_version_":1666138492263989252,"score":40.388584}]}